Synthesis and In Vitro Evaluation of Chitosan-EDTA-Protease-Inhibitor Conjugates Which Might Be Useful in Oral Delivery of Peptides and Proteins

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Pharmaceutical Research

• Publication date

  1998-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1011970703087PMID 9523313
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates.

  1998cited by this paper
• The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.

  1998cited by this paper
• Development and in Vitro Evaluation of Systems to Protect Peptide Drugs from Aminopeptidase N

  1997cited by this paper
• Novel Bioadhesive Chitosan-EDTA Conjugate Protects Leucine Enkephalin from Degradation by Aminopeptidase N

  1997cited by this paper
• Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation

  1997cited by this paper
• Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides

  1997cited by this paper
• Development and analysis of a polymer protecting from luminal enzymatic degradation caused by α-chymotrypsin

  1997cited by this paper
• Synthesis and evaluation of a modified mucoadhesive polymer protecting from α-chymotrypsinic degradation

  1997cited by this paper
• Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation

  1996cited by this paper
• Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles

  1996cited by this paper
• Enzymatic barriers for GI peptide and protein delivery.

  1994cited by this paper
• Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

  1994cited by this paper
• Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats

  1994cited by this paper
• Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.

  1994cited by this paper
• Oral Absorption of Peptides: The Effect of Absorption Site and Enzyme Inhibition on the Systemic Availability of Metkephamid

  1994cited by this paper
• Evidence for the role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialyltransferase from rat and mouse liver in whole-cell systems.

  1993cited by this paper
• Tension inhibitory effect of lead ions and lead uptake in ileal longitudinal muscle of the guinea-pig.

  1993cited by this paper
• Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats

  1992cited by this paper
• Effect of Synthetic Protease Inhibitor Camostate on Pancreatic Exocrine Function in Rats

  1987cited by this paper
• Promoting effect of the new chymotrypsin inhibitor FK‐448 on the intestinal absorption of insulin in rats and dogs

  1985cited by this paper
• Cytotoxic effects of protease inhibitors on human cells. 2. Effect of elastatinal.

  1980cited by this paper
• Hypertrophy and hyperplasia of the neonatal rat exocrine pancreas induced by orally administered soybean trypsin inhibitor.

  1976cited by this paper

• Multidisciplinary methodologies used in the study of cable bacteria

  2024cites this paper
• Generations of Chitosan: The Progress in Drug Delivery

  2021cites this paper
• New vitamin K3 (menadione) analogues: synthesis, characterization, antioxidant and catalase inhibition activities

  2020cites this paper
• Evaluation of the Synergistic Effect of EDTA-Functionalized Chitosan Nanoparticles on Imipenem Delivery in Pseudomonas aeruginosa Carbapenem-Resistant Strain AG1

  2018cites this paper
• Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems

  2018cites this paper
• Mucoadhesive Polymers: Basics, Strategies, and Trends

  2017cites this paper
• Multifunctional adhesive polymers: Preactivated thiolated chitosan‐EDTA conjugates

  2017cites this paper
• Starch-based nanocapsules fabricated through layer-by-layer assembly for oral delivery of protein to lower gastrointestinal tract.

  2017cites this paper
• Trimethyl Chitosan Improves Anti-HIV Effects of Atripla as a New Nanoformulated Drug.

  2017cites this paper
• FORMULATION OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM OF BOVINE SERUM ALBUMIN USING HLB (HYDROPHILIC-LYPOPHILIC BALANCE) APPROACH

  2016cites this paper
• Perspectives of Engineered Marine Derived Polymers for Biomedical Nanoparticles.

  2016cites this paper
• Development and evaluation of a novel insulin analogue

  2015cites this paper
• Drug Delivery Applications of Chitosan and its Derivatives

  2015cites this paper
• Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems.

  2015cites this paper
• Polymers in oral insulin delivery

  2014cites this paper
• Pre-systemic metabolism of orally administered drugs and strategies to overcome it.

  2014cites this paper
• Novel noninvasive techniques in management of diabetes

  2014cites this paper
• Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.

  2013cites this paper
• Mucoadhesive Polymers: Basics, Strategies, and Future Trends

  2013cites this paper
• Recent Development in Applications of Important Biopolymer Chitosan in Biomedicine, Pharmaceuticals and Personal Care Products

  2013cites this paper
• Ethylenediaminediacetic acid bis(carbido amide chitosan): synthesis and evaluation as solid carrier to fabricate nanoemulsion.

  2013cites this paper
• The Synthesis of Poly N-acetyl iodo Glucosamine and its Gelation of Blood.

  2013cites this paper
• Intelligent Drug Delivery Systems Based on Modified Chitosan Nanoparticles

  2012cites this paper
• Oral protein delivery: Current status and future prospect

  2011cites this paper
• Core shell methyl methacrylate chitosan nanoparticles: In vitro mucoadhesion and complement activation

  2011cites this paper
• Chitosan and its salts for mucosal and transmucosal delivery

  2009cites this paper
• Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.

  2009cites this paper
• Thiolated Chitosans: Novel Polymers for Mucoadhesive Drug Delivery – A Review

  2008cites this paper
• Excipients as Absorption Enhancers

  2008cites this paper
• Mucoadhesion and the gastrointestinal tract.

  2008cites this paper
• Properties and Formulation of Oral Drug Delivery Systems of Protein and Peptides

  2007cites this paper
• Current challenges in non-invasive insulin delivery systems: a comparative review.

  2007cites this paper
• The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes

  2007cites this paper
• Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery

  2006cites this paper
• Chitosan nanoparticles for oral drug and gene delivery

  2006cites this paper
• Chitosan-pentaglycine-phenylboronic acid conjugate: a potential colon-specific platform for calcitonin.

  2006cites this paper
• Molecular design of advanced oral protein delivery systems using complexation hydrogels

  2006cites this paper
• Polymeric Systems for Oral Protein and Peptide Delivery

  2005cites this paper
• Thiomers: a new generation of mucoadhesive polymers.

  2005cites this paper
• Thiolated chitosans.

  2004cites this paper
• Hydrogels for oral delivery of therapeutic proteins

  2004cites this paper
• Chitosan chemistry and pharmaceutical perspectives.

  2004cites this paper
• In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases.

  2003cites this paper
• Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.

  2003cites this paper
• Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.

  2003cites this paper
• Oral delivery of proteins: progress and prognostication.

  2002cites this paper
• Peroral route: an opportunity for protein and peptide drug delivery.

  2001cites this paper
• Chemically modified chitosans as enzyme inhibitors.

  2001cites this paper
• Influence of the spacer on the inhibitory effect of different polycarbophil-protease inhibitor conjugates.

  2001cites this paper
• Effects of Doxorubicin (Adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)]propane (ICRF-187) on skeletal muscle protease activities.

  2001cites this paper
• Chitosan: some pharmaceutical and biological aspects ‐ an update

  2001cites this paper
• Polycarbophil-cysteine conjugates as platforms for oral polypeptide delivery systems.

  2000cites this paper
• Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.

  2000cites this paper
• Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration.

  1999cites this paper
• Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.

  1998cites this paper
• The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.

  1998cites this paper